Novartis signs world's first licensing deal for high-priced cancer drug

The oral drug, nilotinib, is used to treat chronic myeloid leukemia and may be made in Egypt, Guatemala, Indonesia, Morocco, Pakistan, the Philippines, and Tunisia

from Latest News https://ift.tt/8xr2ck0
via WebMD https://ifttt.com/images/no_image_card.png